Obesity--a neglected culprit in renal disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Proteinuria is a recognized complication of morbid obesity, although it develops only in a minority of patients. Renal biopsies and autopsy studies have shown that focal and segmental glomerulosclerosis (FSG) is the commonest histologic lesion in proteinuric obese patients [1]. Obesity‐related FSG can be distinguished from idiopathic cases of FSG by glomerulomegaly and by less severe foot process effacement. From a clinical point of view, patients with obesity‐related glomerulopathies (ORG) do not develop the nephrotic syndrome (hypoalbuminaemia, oedema) even when there is massive and sustained proteinuria. This clinical characteristic (that is also observed in other renal diseases related to hyperfiltration such as reflux nephropathy or proteinuria related to renal mass reduction) is very useful to distinguish these patients from idiopathic FSG in which a complete nephrotic syndrome usually accompanies the presence of nephrotic‐range proteinuria [2]. The reasons why patients with ORG do not develop complete nephrotic syndrome remain unexplained but may relate to differences in the tubular management of filtered proteins and in a very slow proteinuria increase over the years which is characteristic of ORG and other hyperfiltering disorders. Initial descriptions of ORG suggested a relatively benign clinical course, based on the normal renal function of reported cases and very short periods of follow up. Recently, we have shown, however, that the long‐term prognosis of obese patients with biopsy‐proven FSG is poor with almost one‐half ultimately developing advanced renal failure [3]. These observations are of interest taking into account that a striking increase in the number of patients diagnosed with ORG in the last years has been reported recently. Thus, a retrospective analysis of all native renal biopsies received in the Renal Pathology Laboratory of Columbia University, New York (n=6818), revealed a progressive increase in biopsy incidence of ORG from 0.2% in 1986–2000 to 2% in 1996–2000 [1]. Studies in obese animals have shown an increased renal blood flow and glomerular filtration rate (GFR), mediated by vasodilation of the afferent arterioles [4]. The cause of these haemodynamic changes could be related to an increased salt reabsorption in the loop of Henle. The elevated salt reabsorption at a segment proximal to the macula densa would induce a rise in GFR through tubuloglomerular feedback, in addition to shifting the pressure natriuresis relationship to higher blood pressure values. The mechanisms responsible for this increased tubular reabsorption are still unclear but several experimental studies have shown that insulin resistance, increased sympathetic activity, and activated renin–angiotensin system (RAS), i.e. disturbances consistently found in obesity, could all play an important role. Studies in humans have confirmed these experimental results, showing an increase in renal plasma flow and GFR, together with increased transcapillary hydraulic pressure and filtration fraction in non‐diabetic, normotensive obese subjects in comparison with non‐obese [5]. Hyperlipidaemia is common in obese patients. Many experimental studies and some clinical data have shown that dyslipidaemia can contribute to renal injury, mainly through proliferation of mesangial cells and their extracellular matrix induced by LDL‐cholesterol. The obese Zucker rat is an experimental model of obesity, hyperinsulinaemia, and hyperlipidaemia that develops glomerulosclerosis and progressive renal failure. Treatment of hyperlipidaemia reduces glomerular injury in obese Zucker rats. Therefore, treatment with statins and other hypolipaemic agents may induce a beneficial effect in ORG, although no clinical studies have addressed this specific issue. Leptin, an adipocyte‐derived hormone, plays a critical role in the control of appetite and energy expenditure. Non‐diabetic obese subjects as well as obese type 2 diabetic patients exhibit high serum leptin levels. Mutations in the Ob‐Rb leptin receptor in the db/db mouse lead to leptin resistance, hyperleptinaemia, obesity, and type 2 diabetes with glomerulosclerosis. Recent studies [6] have shown that leptin stimulates cellular proliferation and expression of the prosclerotic cytokine TGF‐β1 cytokine. Chronic leptin infusion into normal rats induced proteinuria and focal glomerulosclerosis accompanied by elevated glomerular TGF‐β1 and type IV collagen expression. These studies suggest that leptin could play an important role in the pathogenesis of glomerulosclerosis associated with obesity. Other recent studies have provided exciting data about the active role of adipocytes in the hormonal regulation of energy balance. Resistin, another hormone secreted by adipocytes, appears to be crucial in the insulin resistance linked to obesity and type 2 diabetes [7]. Serum levels of resistin are increased markedly in obese experimental animals and are decreased by thiazolidinendiones, drugs curren
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Cited by
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
Obesity and Risk for Chronic Renal Failure
Ejerblad, E., Fored, C. M., Lindblad, P., Fryzek, J., McLaughlin, J. K., & Nyrén, O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005060638 · Cited by 680
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387
Role of Altered Renal Lipid Metabolism in the Development of Renal Injury Induced by a High-Fat Diet
Kume, S., Uzu, T., Araki, S.-I., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Kubota, N., Terauchi, Y., Kadowaki, T., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010089 · Cited by 278
Is obesity a major cause of chronic kidney disease?
Hall, J. E., Henegar, J. R., Dwyer, T. M., Liu, J., da Silva, A. A., Kuo, J. J., & Tallam, L. (2004) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.10.007 · Cited by 264
Metadata
- Authors
- Praga, M.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-07-01
- Volume
- 17
- Issue
- 7
- Pages
- 1157-1159
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2098100684
- Cited by
- 136
- References
- 1
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity--a neglected culprit in renal disease. https://app.cochat.ai/papers/10.1093/ndt/17.7.1157
- The paper
- Praga, M. (2002). Obesity--a neglected culprit in renal disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/17.7.1157
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.